Navigation Links
CSA Medical, Inc. Appoints President
Date:9/30/2008

BALTIMORE, Sept. 30 /PRNewswire/ -- CSA Medical, Inc. announced today the promotion of Steven E. Schaefer to President of CSA Medical, Inc. Steve Schaefer, Chief Financial Officer since November 2006, has been appointed President of CSA Medical, Inc. The Company, headquartered in Baltimore, Maryland, is the world's exclusive provider of a ground-breaking, therapeutic medical device. The device allows physicians to use endoscopes to quickly and easily spray supercool (-196 degrees C) liquid nitrogen onto unwanted tissues deep inside the body. Mr. Schaefer's additional responsibilities for the growth and operations of the company will allow company CEO and Board Chairman Tim Askew to expand the patented platform technology into additional treatment areas. "Steve will focus his efforts on expanding the early success of the GI business of CSA Medical," said Askew. He continued, "Over the past two years he has demonstrated a great capacity to drive visionary growth and has my confidence in taking the business to the next level."

(Photo: http://www.newscom.com/cgi-bin/prnh/20080930/NETU087 )

(Logo: http://www.newscom.com/cgi-bin/prnh/20080721/NEM114LOGO )

CSA Medical has seen impressive growth since commercially launching the CryoSpray product in May 2007. During this time Mr. Schaefer has worked closely with VP of Sales and Marketing, Ric Hughen, to launch and expand sales of CSA Medical's device. In the first year of commercial availability the FDA-cleared technology has been adopted nationwide in over fifty top healthcare institutions and the pace of adoption is continuing to accelerate. "I am committed to drive CSA Medical and its fight against GI diseases to new levels while growing and protecting the remarkable culture of our organization," said Mr. Schaefer.

Steve Schaefer joined CSA Medical, Inc. with a background in finance, marketing, business development and sales leadership. A Certified Public Accountant, and Drexel University graduate, Steve previously has served in executive roles at several high-growth technology companies including RewardsPlus and FiberTech Medical.

About CSA Medical: CSA Medical, Inc is the manufacturer of the CryoSpray Ablation(TM) System. The CSA System utilizes a patented spray cryogenic technology that allows a physician to safely and effectively destroy a wide range of unwanted tissues via an endoscope.

For more information, please contact Richard Hughen at rhughen@csamedical.com.


'/>"/>
SOURCE CSA Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Medical, technological advances prompt updating of nuclear medicine technologists scope of practice
2. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
3. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
4. Thermage, Inc. Announces Distribution Agreement With Eclipse Medical, Ltd.
5. Medical, Behavioral Woes Can Drive Dogs to Bite
6. ReBuilder Medical Technologies, Inc. Announces UK Demand for Safe Molluscum Contagiosum Treatment Leads to Distribution Agreement with UFFE Medical, LTD. Expected 10% Sales Increase.
7. Sedgwick CMS and UnitedHealth Group to Develop Integrated Disability, Medical, Workers Compensation and Leave Administration Services for Employers
8. Emmaus Medical, Inc. Enters Into Sub-License Agreement for Treatment of Short Bowel Syndrome
9. XCPT(TM) Patient Engagement and Communication Software Signs Representation Agreement with Lifecore Biomedical, Inc. (Nasdaq: LCBM)
10. Gary Tschautscher of Nonin Medical, Inc. Receives CEO of 2007 for North American Patient Monitoring From Frost & Sullivan
11. Cardiva Medical, Inc. Appoints Two New Officers: Malcolm Farnsworth as Vice President of Finance and Chief Financial Officer and Tara Zerby as Vice President of Business Development and Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... , media relations, content marketing, social media management, corporate communications, SEO and cause ... the state and in nearby New Hampshire, Massachusetts and Canada, Rosica will focus ...
(Date:2/23/2017)... Colorado (PRWEB) , ... February 23, 2017 , ... ... Magazine, an exciting, new, interactive publication where generations converge and explore the world ... expand their worldview, Dialog Magazine enables readers to gain understanding, increase empathy, and ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... new partnership with the Rhode Island Consortium for Autism Research and Treatment (RI-CART) ... for children with autism spectrum disorder (ASD) to see films in an environment ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/22/2017)... York (PRWEB) , ... February 22, 2017 , ... ... entrance and lobby of a new healthcare contact center in Georgia, PENETRON Specialty ... One of the nation’s largest healthcare systems recently invested $51 million to purchase ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017  Cogentix Medical, Inc. ... and markets innovative proprietary products for the urology market, ... fiscal year ended December 31, 2016 before the market ... The Company will host a conference call and webcast ... Thursday, March 9, 2017 at 11:00 a.m. Eastern Time ...
(Date:2/23/2017)... Feb 23, 2017 Research and Markets has announced ... 2016" report to their offering. ... The latest research Menopause Drugs Price Analysis and Strategies - ... The research answers the following questions: ... How are they positioned in the Global Menopause market? ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... - 2016" report to their offering. ... The latest research Fibromyalgia Drugs Price ... in the global Fibromyalgia market. The research answers the ... marketed for Fibromyalgia and their clinical attributes? How are they positioned ...
Breaking Medicine Technology: